Agile Therapeutics, Inc. appointed Scott Coiante to serve as Senior Vice President and Treasurer, effective August 16, 2023. The Company has engaged its independent compensation consultant to assist the Company in preparing compensation arrangements for Mr. Coiante. The Company will file an amendment to this Current Report on Form 8-K including as an exhibit the employment agreement to be entered into between the Company and Mr. Coiante once it has been executed.

Mr. Coiante, age 56, joined the Company from Aprea Therapeutics, Inc. where he served as the Chief Financial Officer from August 2019 until January 2023 and remained as an employee through March 31, 2023. Prior to joining Aprea Therapeutics, Inc., Mr. Coiante served as the Company’s Senior Vice President and Chief Financial Officer from 2010 to August 2019. From 2002 to 2010, Mr. Coiante was Vice President of Finance and Treasurer at Medarex, Inc., formerly a NASDAQ listed biotech company that was acquired in 2009 by Bristol Myers Squibb.

From 1989 to 2002, Mr. Coiante held management positions of increasing responsibilities at Ernst & Young LLP. Mr. Coiante received a B.S. in Accounting from Villanova University. There are no arrangements or understandings between Mr. Coiante and any other person pursuant to which he was selected for the positions to which he was appointed.

? On June 21, 2023, the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch will separate from service as the Chief Accounting Officer, effective August 15, 2023. Mr. Butch will remain with the Company through August 15, 2023, and his compensation will remain unchanged during that time.

The Company thanks Mr. Butch for his service and contributions to the Company.